Lifecore Biomedical

Yahoo Finance • 6 months ago

Hidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar

In this article we are going to reveal the names of 10 stocks that are on hedge funds' radar. The US market sustained strong performance in the first quarter of 2024 as the S&P Index increased by 10.6%, continuing its momentum from the pr... Full story

Yahoo Finance • 6 months ago

What Made White Falcon Hold Lifecore Biomedical (LFCR)?

White Falcon Capital Management, an investment fund manager, released its first quarter 2024 investor letter.  A copy of the same can be downloaded here. The portfolio achieved a satisfactory result on an absolute basis during the quarter.... Full story

Yahoo Finance • 10 months ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Lifecore Biomedical, Inc. Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO CHASKA, M... Full story

Yahoo Finance • 12 months ago

Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods

CHASKA, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that the U.S. Department of Justice (the “DOJ”) has declined to prosecute the Company for violations of the Foreign... Full story

Yahoo Finance • last year

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report

CHASKA, Minn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on October 12, 2023 from the Listing Qualifications Department of The Nasdaq S... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR). Such investors are advised to contact Robert S. Willough... Full story

Yahoo Finance • 2 years ago

Should You Hold Lifecore Biomedical (LFCR)?

Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund returned 2.83% compared to 2.74% f... Full story